Optimizing CDK4&6 Inhibitor Treatment Outcomes

Overview

We are pleased to invite you for the next MBC TALKS webinar and
live Q&A session where Prof. Eva Ciruelos, Prof. Mark Thill and
Maria Noblet R.N. will discuss different CDK4&6i trials from an
endocrine resistance perspective with a focus on Abemaciclib and side
effects management.

This Activity for

• Resident / Fellow
• Physician
• Clinical Pharmacy

What I will learn?

- An overview of different CDK4&6i trials from an endocrine resistance perspective - 10 min
- Abemaciclib treatment, side effects management - 10 min
- Panel Discussion and live Q&A - 40 min

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
Optimizing CDK4&6 Inhibitor Treatment Outcomes Certificate	Certificate	Free

VAT 15% Included